The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome
- PMID: 8839607
- DOI: 10.1097/00019052-199606000-00004
The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome
Abstract
This review covers current hypotheses regarding antigen-specific disease induction, immune responses within the central and peripheral nervous systems, the nonspecific inflammatory cascade, and mechanisms responsible for demyelination, axonal loss, and disease progression in multiple sclerosis and Guillain-Barré syndrome. We also discuss the new evidence on the role of infection as an aetiological factor in multiple sclerosis and Guillain-Barré syndrome.
Similar articles
-
Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.Ann Neurol. 1991 Jul;30(1):48-53. doi: 10.1002/ana.410300110. Ann Neurol. 1991. PMID: 1929228
-
Pathogenesis of neuroimmunologic diseases. Experimental models.Immunol Res. 1998;17(1-2):217-27. doi: 10.1007/BF02786446. Immunol Res. 1998. PMID: 9479583 Review.
-
Observations on the effect of injection of lymphocytes from multiple sclerosis and Guillain-Barré syndrome in the rabbit eye model.J Neurol Sci. 1979 Jul;42(2):283-9. doi: 10.1016/0022-510x(79)90060-1. J Neurol Sci. 1979. PMID: 479915
-
Pathology of the motor-sensory axonal Guillain-Barré syndrome.Ann Neurol. 1996 Jan;39(1):17-28. doi: 10.1002/ana.410390105. Ann Neurol. 1996. PMID: 8572662
-
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.Ann Neurol. 1995 May;37 Suppl 1:S14-31. doi: 10.1002/ana.410370704. Ann Neurol. 1995. PMID: 8968214 Review.
Cited by
-
Vasoactive intestinal polypeptide suppressed experimental autoimmune encephalomyelitis by inhibiting T helper 1 responses.J Clin Immunol. 2006 Sep;26(5):430-7. doi: 10.1007/s10875-006-9042-2. Epub 2006 Sep 10. J Clin Immunol. 2006. PMID: 16964563
-
IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS).Clin Exp Immunol. 1998 Jan;111(1):193-7. doi: 10.1046/j.1365-2249.1998.00478.x. Clin Exp Immunol. 1998. PMID: 9472681 Free PMC article.
-
A little stress is good: IFN-gamma, demyelination, and multiple sclerosis.J Clin Invest. 2007 Feb;117(2):297-9. doi: 10.1172/JCI31254. J Clin Invest. 2007. PMID: 17273549 Free PMC article.
-
Neuropathobiology of COVID-19: The Role for Glia.Front Cell Neurosci. 2020 Nov 11;14:592214. doi: 10.3389/fncel.2020.592214. eCollection 2020. Front Cell Neurosci. 2020. PMID: 33304243 Free PMC article. Review.
-
Management of secondary-progressive multiple sclerosis.CNS Drugs. 2004;18(10):653-69. doi: 10.2165/00023210-200418100-00003. CNS Drugs. 2004. PMID: 15270594 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical